What is the NOAEL for 3-Phenyl-2-propen-1-ol?
3-Phenyl-2-propen-1-ol has 100 NOAEL studies in the database. The lowest reported value is 0 % via Dermal. Source: NTP_ICE_skin_sensitization.
Also known as: Cinnamyl alcohol, 1-06-00-00281, BRN 1903999, EINECS 203-212-3, FEMA No. 2294 (+6 more)
CAS 104-54-1
3-Phenyl-2-propen-1-ol (CAS 104-54-1) is a chemical substance. Key regulatory status: REACH registered, 28 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe | Danish Environmental Protection Agency | Danish EPA |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| Cleaning products and household care - air freshener; detected; Europe; Vehicle - car interior - auto air freshener | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care - specialized bath products - bath salts | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; detected; Europe; Personal care - body hygiene - body wash | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - dishwasher and dishes; Cleaning products and household care - laundry and fabric treatment - fabric softener; detected; Europe; Other direct contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| consumer_product; detected; Europe | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - laundry and fabric treatment - laundry stain remover; detected; Europe | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - laundry and fabric treatment - laundry stain remover; detected; Europe | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Personal care - sexual wellness | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Personal care - sexual wellness | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - sexual wellness | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Personal care - sexual wellness | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - deodorant | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Personal care - deodorant | Danish Environmental Protection Agency | Danish EPA |
| Australia; Food and drug - smoking-related products | New Zealand ESR | CPCat |
| Europe; Personal care; restricted | European Commission | CosIng |
| IFRA Transparency | IFRA | IFRA |
| Europe | European Commission | Fl@vis |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Canada; pharmaceutical | DrugBank | DrugBank |
| Canada; pharmaceutical | DrugBank | DrugBank |
| consumer_product | P&G | Proctor & Gamble |
| Cleaning products and household care - laundry and fabric treatment - laundry detergent; Europe | Danish EPA | Danish EPA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 62.9650975954467 | uM | AC50 | - | - | NTP_ICE_endocrine |
| 42.079892248649 | uM | ACC | - | - | NTP_ICE_endocrine |
| 97 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 196.6 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 21.41 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 73 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 76.803 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 101.6 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 147 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 109.71 | ug/mL | CV70 | Dermal | - | NTP_ICE_skin_sensitization |
| 206.9 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 350 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 1.389 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.65 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.786 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.167 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.333 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 3.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4.167 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| range4.2 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5.4 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5.75 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 7.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 8.1 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 14 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.111 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.429 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.667 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 2 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 3.333 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 4 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 5 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 10 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| =2.64 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| - | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 21.3 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 2.1 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 2.7 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 15.1 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 7.6 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 12 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 24 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 59.55 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 61.3 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 70.47 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 82.65 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
Showing 50 of 100 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Cinnamyl alcohol | 203-212-3 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS food additive, ADI, and GRAS records where available.
ADI: No safety concern at current levels of intake when used as a flavouring agent mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →3-Phenyl-2-propen-1-ol has 100 NOAEL studies in the database. The lowest reported value is 0 % via Dermal. Source: NTP_ICE_skin_sensitization.
3-Phenyl-2-propen-1-ol appears on 20 regulatory/inventory lists including Europe, inert_ingredient; non_food_use; Pesticides, Cleaning products and household care - air freshener; detected; Europe; Vehicle - car interior - auto air freshener, and 17 more. Source: EPA CPDat.
Yes, 3-Phenyl-2-propen-1-ol is also indexed as a cosmetic ingredient under the name Cinnamyl Alcohol. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
3-Phenyl-2-propen-1-ol also appears in cosmetics, food safety, cannabis databases.